GKOS — Glaukos Corporation

Ownership history in RIVERBRIDGE PARTNERS LLC  ·  19 quarters on record

This page tracks every 13F SEC filing in which RIVERBRIDGE PARTNERS LLC reported a position in Glaukos Corporation (GKOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.13% (2025 Q4)
Avg. % of fund
0.56%
First filed
2021 Q2
Last filed
2025 Q4
Quarters held
19
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 535,169 -34,475 -6.1% 1.13% $60.4M $112.91
2025 Q3 ADDED 569,644 +165,673 +41.0% 0.78% $46.5M $81.55
2025 Q2 ADDED 403,971 +118,509 +41.5% 0.67% $41.7M $103.29
2025 Q1 REDUCED 285,462 -27,469 -8.8% 0.45% $28.1M $98.42
15 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GKOS price (monthly, adj. close)

Other funds also holding GKOS

As of 2025 Q4 — sorted by position size

BRAIDWELL LP 3Y 3.33% BROWN CAPITAL MANAGEMENT LLC 3Y 7Y 3.02% PFM Health Sciences, LP 3Y 7Y 2.27% Rhenman & Partners Asset Management AB 3Y 7Y 2.22% Resolute Capital Asset Partners LLC 3Y 2.21% Integral Health Asset Management, LLC 3Y 1.82% Exome Asset Management LLC 1.7% Capricorn Fund Managers Ltd 3Y 1.63% Taylor Frigon Capital Management LLC 3Y 7Y 1.62% Sofinnova Investments, Inc. 3Y 7Y 1.4%
← Back to RIVERBRIDGE PARTNERS LLC Holdings